ODDB.org: Open Drug Database | Drugs

Fresenius Kabi (Schweiz) AG - Irinotecan Fresenius 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	61246	Sequence	03
Product name	Irinotecan Fresenius 300 mg/15 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01XX19	ATC-Description	Irinotecan
Introduction of Sequence	28.01.2011

Composition

irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300mg / 15ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

Inactive agents	Dose
Acidum Hydrochloridum ad Ph
Lactic Acid
Natrii Hydroxidum ad Ph
Sorbitol	675mg / 15ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
019		245.64	283.55	A	SL	No

2025	©ywesee GmbH